unlearn.healthAbout company
Unlearn.AI develops a platform designed to make computational clinical trials. The company's platform accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, which helps in reducing the time to develop new medicines, enabling healthcare companies to sooner provide patients in need with life-saving therapies. Unlearn.AI helps biopharma companies develop drugs more ethically and efficiently by leveraging generative machine learning models to reduce the number of patients required for placebo controls in clinical trials. Unlearn.AI enables clinical trials that are twice as fast, require fewer patients, produce better evidence about therapeutic efficacy, and in which fewer patients need to be given placebos. Unlearn.AI was founded in 2017 and is headquartered in San Francisco, California.
